Treace Medical Concepts Inc TMCI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $4.10
- Day Range
- $4.05–4.16
- 52-Week Range
- $1.17–7.08
- Bid/Ask
- $3.58 / $5.13
- Shares Outstanding
- 65.03M
- Market Cap
- $266.64M
- Volume/Avg
- 112,186 / 319,386
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.29
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 450
- Website
- https://www.treace.com
Valuation
|
Metric
|
TMCI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.96 |
Price/Sales | 1.29 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
TMCI
|
|---|---|
Quick Ratio | 1.79 |
Current Ratio | 2.90 |
Interest Coverage | −9.59 |
Quick Ratio
TMCI
Profitability
|
Metric
|
TMCI
|
|---|---|
Return on Assets (Normalized) | −13.94% |
Return on Equity (Normalized) | −31.89% |
Return on Invested Capital (Normalized) | −14.84% |
Return on Assets
TMCI
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|x@Mkw%b | LOCK|Xk^jy | $178B | |||
| Medtronic PLC
MDT
| LOCK|xwHfFFg | LOCK|p>?pr | $119B | |||
| Stryker Corp
SYK
| LOCK|PxhRQf> | LOCK|#@g | $108B | |||
| Boston Scientific Corp
BSX
| LOCK|^$y?^!y | LOCK|?^D^ | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|nR?gh^C | LOCK|ph<w# | $49B | |||
| DexCom Inc
DXCM
| LOCK|br>>gy@ | LOCK|C^&$ | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|g&zY<^ | LOCK|!g | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|>>v | LOCK|?s> | $24B | |||
| Steris PLC
STE
| LOCK|jgFZ^?j | LOCK|#^lY | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|lvl^C>@g | LOCK|B@ | $18B |
United States